BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 32724813)

  • 1. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
    Zheng L; Dou X; Ma X; Qu W; Tang X
    Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
    Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
    Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line.
    Li W; Wang S; Qiu C; Liu Z; Zhou Q; Kong D; Ma X; Jiang J
    J Transl Med; 2019 Feb; 17(1):58. PubMed ID: 30813939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9
    Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C
    Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioinformatics Analysis Identifies Hub Genes and Molecular Pathways Involved in Sepsis-Induced Myopathy.
    Ning YL; Yang ZQ; Xian SX; Lin JZ; Lin XF; Chen WT
    Med Sci Monit; 2020 Feb; 26():e919665. PubMed ID: 32008037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis and Identification of Genes and Molecular Pathways Involved in Synovial Inflammation in Rheumatoid Arthritis.
    Xiong Y; Mi BB; Liu MF; Xue H; Wu QP; Liu GH
    Med Sci Monit; 2019 Mar; 25():2246-2256. PubMed ID: 30916045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Skt11-regulated genes in chondrocytes by integrated bioinformatics analysis.
    Liang S; Zhang JM; Lv ZT; Cheng P; Zhu WT; Chen AM
    Gene; 2018 Nov; 677():340-348. PubMed ID: 30107230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
    Baruah MM; Sharma N
    Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hub Genes and Key Pathway Identification in Colorectal Cancer Based on Bioinformatic Analysis.
    Lv J; Li L
    Biomed Res Int; 2019; 2019():1545680. PubMed ID: 31781593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer.
    Liu BX; Huang GJ; Cheng HB
    J Comput Biol; 2019 Nov; 26(11):1262-1277. PubMed ID: 31211595
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of biomarkers, pathways and potential therapeutic target for docetaxel resistant prostate cancer.
    Liu RJ; Li SY; Liu LQ; Xu B; Chen M
    Bioengineered; 2021 Dec; 12(1):2377-2388. PubMed ID: 34077304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.